Figure 2.

HLA-profile of the study population (n = 34) investigating HLA-A1, -B8, -DR3, and -DR4 status (A), and antibody-profile of the study population (n = 52) demonstrating positivity for ANA-, AMA-, SMA-, SLA-, ANCA-, and LKM-titers (B). ANA: Anti-nuclear; SMA: Anti-smooth muscle; LKM: Anti-liver kidney microsomal.